Home › Former Biogen exec to lead Newton biotech, Chiasma
 

Keywords :   


Former Biogen exec to lead Newton biotech, Chiasma

2015-03-16 21:21:07| Biotech - Topix.net

A longtime pharmaceutical executive who oversaw the launch of Biogen Idec's first multiple sclerosis drug, Avonex, has been named CEO of a privately held Newton biotech. Chiasma Inc., which recently raised $70 million in Series E financing and last week told the Boston Business Journal that it's in the process of looking for a new, larger headquarters in either Newton or Cambridge, today named Mark Leuchtenberger as its president and CEO.

Tags: lead newton biotech exec

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Tropical Storm Joyce Wind Speed Probabilities Number 6
More »